InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
3.490
-0.120 (-3.32%)
Nov 18, 2026, 4:00 PM EST - Market closed
InterCure Market Cap
InterCure has a market cap or net worth of $40.74 million as of November 18, 2026. Its market cap has decreased by 46.20% in one year.
Market Cap
40.74M
Enterprise Value
82.22M
1-Year Change
-46.20%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.77M to $40.74M, an increase of 2,203.71%. That is a compound annual growth rate of 21.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 40.74M | -26.61% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 86.90M |
| Zhengye Biotechnology Holding | 72.03M |
| Citius Oncology | 57.91M |
| Talphera | 41.57M |
| Aytu BioPharma | 28.91M |
| SCYNEXIS | 28.37M |
| Rockwell Medical | 26.64M |
| TherapeuticsMD | 22.11M |